INTEGRITI-TIMI 20

INTEGRITI-(TIMI 20) evaluated the safety and efficacy of the combination of eptifibatide and TNK among 438 patients presenting with ST elevation myocardial infarction. MAIN RESULTS: Combination reperfusion therapy with eptifibatide and reduced-dose tenecteplase for ST-elevation myocardial infarction: results of the integrilin and tenecteplase in acute myocardial infarction (INTEGRITI) Phase II Angiographic Trial J Am Coll … Continue reading INTEGRITI-TIMI 20